DatasetName,CDC42BPB_S(1029) CDC42BPB_S(15) CDC42BPB_S(1640) CDC42BPB_S(1659) CDC42BPB_S(1683) CDC42BPB_S(1686) CDC42BPB_S(1690) CDC42BPB_S(1693) CDC42BPB_S(363) CDC42BPB_S(365) CDC42BPB_S(481) CDC42BPB_T(1678) CDC42BPB_T(676) CDC42BPB_T(858) CDC42BPB_Y(1638) CDC42BPB_Y(357),CDC42BPB_S(437) CDC42BPB_S(707)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5134495765117985,
SR2019_MCF7_Biol_repl_3,0.4838125173755429,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5153238521773575,
SR2019_LM2_Biol_repl_1,0.4919206253643044,
RCJD2014_15min_1,0.5402809266090235,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,0.4727535785215822,
AH2018_LFQ_IT_1_C,0.49172744535803287,
RKK2015_TNF-α/basal,0.5172643634855717,
JJ2018_Ratio H/M normalized pP2,0.4914673539038133,
NJH2025_Sub12_MICT_Pre,0.48348370799157264,
NJH2025_Sub7_MICT_Post,0.4715318989826655,
DL2023_control-3,0.49720834303207523,
ZX2022_Control Replicate 2,0.4945764718804574,
HS2024_6_B_T3,0.49510861861295064,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.49870994831549487,
SR2019_MDAMB231_Biol_repl_4,0.4917455339150993,
GF2025_P2_Sph,0.49915421613458677,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.475966464506058,
FSO2013_Ratio M/L normalized Rep1___1,0.485755302762693,
SAS2015_AZD/DMSO_Exp3,0.49557326299278387,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,0.5059637417068408,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5000857746839211,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,0.5028241217245134,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.4949356133101886,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.49165489706182103,
FSO2013_Ratio M/L normalized Rep3___3,0.47228828413414814,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,0.4961983626281489,
ZQ2022_C2,0.508595709474277,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.514601728106078,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,0.5039545549450265,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5098463675498901,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.4947622941867272,
RM2024_Intensity D6-2___3,0.505548890993179,
WZ2023_Pe_025_10min,0.4918256963080982,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.4966601947994626,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,0.47158602047034737,
CK2022_9 40-1,0.4867011482201532,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.4940482268667312,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.48578883989931404,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.49133317849242464,
FR2021_Norm.Intensity.B,0.5041663278542605,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.5083420504825309,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.4963990972190247,
CR2017_Ratio Replicate 1.3,0.49097957251959345,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,0.5016359869444028,
AH2018_SILAC_M_2_N,0.4899106367405792,
HS2024_7_PD_T2,0.5067549987471102,
FSO2013_Ratio H/L normalized Rep1___1,0.4937667356317238,
AH2018_LFQ_1_C,0.4932864447201845,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.507414300081448,
RM2024_Intensity D4-2___3,0.5033936595206806,
WZ2023_Pe_025_30min,0.4943048560545257,
CK2022_11 40-1,0.48424897094781866,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,0.5147483989769007,
WZ2023_Pu_005_20min,0.5032692209429566,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.48177036687246844,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.4916526625184486,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.4989721335472667,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,0.5025189640009111,
AH2018_LFQ_M_1_C,0.4951248914564752,
NJH2025_Sub7_MICT_Pre,0.47869525609517216,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5040517007515061,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5023502629677944,
FSO2013_Ratio M/L normalized Rep3___2,0.5082223337352315,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.4999791637040751,
FR2021_Norm.Intensity.H,0.5080426301679607,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.4941806203692511,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.4850472907780436,
PG2020_Intensity Mock_10h_D,0.5014627038244672,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4996945115409513,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,0.5030013737387311,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5061800477216732,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.4990843824814439,
CR2017_Ratio Replicate 3.3,0.49599278275700454,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.4942595821701381,
KBE2022_Log2_Ex_8_T,0.49011191455274744,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.4995201508079349,
RN2012_L11,0.5118789166623883,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.49728094109860227,
AH2018_LFQ_M_2_C,0.4931872523584012,
CK2022_3 40-1,0.4857314756628554,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5021929322696471,
YA2020_Reporter_intensity_Cancer_No.5,0.488254015343187,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.4787069011198662,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,0.5243485242087925,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,0.4952559296992101,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4927767074491935,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,0.49237530298007937,
HS2024_3_B_T1,0.4866687683852422,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),0.4818808337956322,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),0.49335384191996556,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.49128566008667385,
HS2024_8_I_T3,0.49580735131041886,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.511927693172999,
DL2023_12h-2,0.4993690054572554,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5030035332268546,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.4867899396999546,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,0.4727535785215822,
AH2018_LFQ_IT_1_N,0.49223187661583845,
FSO2013_Ratio H/M normalized Rep2,0.4758274037530605,
RAM2015_Log2 A,0.5187681795265251,
HS2024_8_PD_T1,0.4997458581818995,
JJ2018_Ratio H/L normalized pP2,0.4929522322939534,
CF2017_OSE 27,0.49404839262980405,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.48055758017369193,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.5029728593812605,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.49771098975924377,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,0.4753798444779352,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5098804252105434,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.4905711950348772,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,0.4938509331931818,
KBE2022_Log2_Ex_27_T,0.5026201618058778,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.4878946094350425,
FSO2013_Ratio M/L normalized Rep2,0.5207047030121941,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.48722989551023566,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,0.4819008616785534,
PG2020_Intensity 4h_D,0.4969995215757294,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.49080995794033605,
DL2023_control-1,,
AR2021_ALG 10 μM,0.49987204859839623,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,0.4960454424013302,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,0.4654647230628765,
GF2025_P2_Adh,0.4902796547336203,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.4999242990814532,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5031699122881889,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.4996046169420706,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.4833842591688257,
CK2022_12 200-1,0.4838876068415906,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,0.49842585878399187,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.49999369110744196,
AH2018_TMTMS2_2_N,0.49499833985362746,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.4847280739615692,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.4809256295395598,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,0.48099166588730147,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4938978882952012,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.49818298393635024,
SR2019_LM2_Biol_repl_4,0.4926609301137544,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.48749801189974407,
GF2025_P1_Sph,0.49956439621809867,
EJN2021_5_Ex_Basal,0.4974951038307369,
HS2024_7_I_T3,0.513663593702295,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4921104760263701,
CF2017_EOC 1,,
CK2022_3 200-1,0.4837942025120192,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,0.488947467447196,
NJH2024_Sub12_HIIT_Post,0.4754631987117839,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),0.4810791301932069,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.4900748402124278,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5142888071346933,
HS2024_5_B_T1,0.5023115104027406,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.4992727914605494,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.4946702978880557,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.48815114610266,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4825410333509058,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),0.49843749346150795,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.4923798811011186,
HS2024_4_B_T1,0.48026316721301926,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.499066265865149,
NJH2025_Sub8_MICT_Post,0.48142058427067724,
RCJD2014_5min_3,0.5102460613800156,
CR2017_Ratio Replicate 3.2,0.5071834690380571,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5022309692565258,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.47969572933256444,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.48341805087664463,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,0.4867418560575903,
NJH2024_Sub9_MICT_Pre,0.48304922055411575,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.49796456988487264,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.4868294319132919,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.49049401170976525,
AH2018_LFQ_M_1_N,0.4920032561769078,
KBE2022_Log2_Ex_27_U,0.5019973113991959,
HW2015_Ratio M/L normalized Exp3,0.49055743350840064,
RKK2015_TNF-α/IKKb(K44M),0.5015494066694406,
AH2018_SILAC_M_1_N,0.49256378034514986,
HW2015_Ratio M/L normalized Exp1,0.5047905406397668,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.49849661887362523,
NJH2025_Sub9_MICT_Post,0.48019147855036604,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.49395992575261843,
SR2019_SKBR3_Biol_repl_3,0.4938696290392245,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.4865436302821793,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,0.498228850042515,
HS2024_6_I_T2,0.49535932402097405,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4982412698534164,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.48512581392252707,
NJH2024_Sub12_HIIT_Pre,0.48099166588730147,
NJH2024_Sub8_MICT_Pre,0.48080325583449096,
RM2024_Intensity D0-1___1,0.5034087236262353,
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),0.5013080975419628,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.5027495762192565,
AH2018_TMTMS2_3_X,0.4955204592895295,
GF2025_P3_Adh,0.5087423288475678,
SR2019_JIMT1_Biol_repl_2,0.4910628596871726,
AH2018_TMTMS2_1_C,0.4943808995031107,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,0.4910004788590623,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5015905032617998,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.49394400315957365,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.49843650753470864,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,0.48019147855036604,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.49838222209975147,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5073990417362454,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,0.480079139962594,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5000239560287302,
AH2018_LFQ_1_X,0.4930779592592628,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.48908315826282084,
FR2021_Norm.Intensity.M,0.5032773372234071,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4906426705302124,
SR2019_MCF7_Biol_repl_1,0.48659280724047016,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.4984338722131295,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,0.49175846264249407,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5164473770878666,
AR2021_KD 72h,0.48953838392364324,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.49173246717392594,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,0.48142058427067724,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.4896507122100478,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.4918559060045795,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.49976963983886236,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.49474568556780263,
PG2020_Intensity 10h_A,,
RN2012_L12,0.49973795093573314,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,0.4654647230628765,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,0.49610297000912273,
FR2021_Norm.Intensity.A,0.5028211184769679,
FSO2013_Ratio H/M normalized Rep1___1,0.49255528064300597,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.48349358245790763,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,0.4754631987117839,
EJN2021_4_Ex_Basal,0.49774057003198047,
TM2022_S2.12h.B,,
RN2012_L15,0.5036828629477075,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.4918743210181999,
FSO2013_Ratio H/M normalized Rep2___2,0.47128037772638964,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4939796418538652,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.4863742397626358,
CK2022_7 200-1,0.4850688294239806,
CK2022_5 200-1,0.48496739325219607,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.49862530283797774,
FSO2013_Ratio H/L normalized Rep2___1,0.500949211000568,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.4911946015549877,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,0.5034765942548178,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.4937996511159513,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.4718137359666284,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.4924414325346314,
EJN2021_2_Ex_Ins,0.49901646389958715,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.4897411709802536,
SAS2015_PLX/DMSO_Exp1,0.498797291919418,
SFR2015_HL_log2_ratio_avg_c,0.5025719575247276,
JJ2018_Ratio M/L normalized pP2,0.4995831347150025,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5238676384657043,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5242795934751496,
JJ2018_Ratio M/L normalized,0.5006594383293758,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.4937698993132026,
KBE2022_Log2_Ex_9_T,0.49091377143039094,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,0.49683146847519816,
HS2024_7_PD_T1,0.5137204634238772,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5132422130449913,
WZ2023_Pe_025_20min,0.49656787881508807,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.4970679362346855,
AH2018_TMTMS2_3_N,0.4948071923568832,
RN2012_H06,0.49804901304912924,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.48715966768385344,
WZ2023_Su_005_30min,0.5002772808190391,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,0.5001023667712656,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,0.5070586474748278,
WZ2023_Su_005_20min,0.5027191513179168,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4934548078649196,
MV2014_Ratio H/M normalized A2___1 (2 min),0.5073754438330219,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,0.5070265641710737,
PG2020_Intensity 4h_C,0.4818399724788617,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.4815827632529559,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.4753184783883508,
NJH2025_Sub8_HIIT_Pre,0.480079139962594,
JJ2018_Ratio H/L normalized pP2___1,0.4928702942507534,
HS2024_8_I_T2,0.5051552603688689,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.498956997772561,
MV2014_Ratio M/H normalized B3___2 (30 min),0.4988818554474212,
CK2022_16 200-1,0.48060868125904765,
VOI2024_0.1uM 2 h_3 di,0.49804202532845354,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.4992378156869124,
CK2022_6 200-1,0.48575042402936996,
NJH2024_Sub7_MICT_Post,0.4715318989826655,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,0.4654647230628765,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5207570993562944,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.47932689975853965,
SAS2015_AZD/DMSO_Exp1,0.5011034695766823,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.5021029371894009,
MV2014_Ratio L/H normalized A3___2 (2 min),0.4966612677651747,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.49641600657336177,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,0.4752895619809012,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4839777595962294,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4995103639734265,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,0.4982880813581436,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.49780382668391904,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.5012095854558132,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5064501123501778,
KBE2022_Log2_Ex_29_T,0.4924261139392437,
HS2024_7_I_T2,0.5040761979255962,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.49629652699881743,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.495698930980501,
EJN2021_1_Ex_Basal,0.49739359456519705,
FR2021_Intensity.M,0.5032773372234071,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.48676108153119035,
ZCP2016_Ratio H/L Rep 1,0.5019901463395762,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),0.4974305075505659,
CR2017_Ratio Replicate 3.4,0.5044638866037063,
HS2024_8_PD_T2,0.4750543956224621,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.5054763730770006,
NJH2025_Sub9_HIIT_Post,0.4753798444779352,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5021892833661177,
RM2024_Intensity D4-3,0.5055364340907491,
HS2024_8_B_N1,0.4813941954990423,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5103008154528792,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.503267602800106,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5048475171632385,
YA2020_Reporter_intensity_Normal_No.2,0.4936725369935303,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4884868337094244,
HS2024_3_PD_T3,0.5049599443624975,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.5080035992569418,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.47510525212219956,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4908914817292661,
CK2022_2 16-1,,
RAM2015_Log2 B,0.49020847790340516,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.508359627042068,
NJH2025_Sub8_MICT_Pre,0.48080325583449096,
EJN2021_4_Rest_Basal,0.4948669288663528,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.4981916312964721,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5033917239731186,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.48443649805199224,
PG2020_Intensity Mock_10h_B,0.4950227695677618,
WZ2023_Su_025_30min,0.5026547525378681,
AH2018_LFQ_4_N,0.49281614888088915,
CR2017_Ratio Replicate 1.2,0.4821459141363476,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.47761805540653646,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.4919294846816011,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.49801640910167577,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5024088980707048,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.501389236607461,
NJH2025_Sub7_HIIT_Mid,0.4654647230628765,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,0.49442322434734,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,0.5030820833303943,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5057742163577661,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.47120933717818303,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.4947794711675958,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.49294072262857586,
PG2020_Intensity 2h_B,0.4902953066101097,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4904365061705466,
GF2025_P3_Sph,0.49951132086969274,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.49172533823243814,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5203975056578106,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.4952646934244749,
CR2017_Ratio Replicate 2.4,0.4852006586407217,
ZQ2022_N1,0.48529068243883244,
LY2019_P6-,,
RM2024_Intensity D2-3,0.5027716486282043,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,0.4990763511542131,
NJH2025_Sub12_MICT_Post,0.4823965087661801,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4876957119112228,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,0.4880069171008581,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.4960067776303214,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.4972282200414967,
JJ2018_Ratio H/L normalized pP3,0.4997868844318598,
CK2022_7 40-1,0.48400283855760595,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.49293037378164745,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.49622199699618963,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.47854593541817886,
WZ2023_Su_025_20min,0.5031091223259797,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.5009881410726061,
FSO2013_Ratio H/L normalized Rep1,0.49095191004399025,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.49959940851242013,
CK2022_13 40-1,0.4859828886509672,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.4999009838442129,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.4944418186152408,
EJN2021_4_Ex_Ins,0.49359420268052245,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.49880275234178467,
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,0.5281432994177119,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.46806516501978146,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,0.49320427740214706,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.49647803509945837,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.4994266014854299,
RN2012_H04,,
CK2022_6 40-1,0.4840425469900656,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,0.5003914808573096,
EJN2021_3_Ex_Ins,0.49594509650472446,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.49983747684789054,
HS2024_8_PD_T3,0.5153821876151767,
EJN2021_3_Ex_Basal,0.4956654237497493,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5031966576754938,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5084627927658071,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.4899366427193123,
FR2021_Norm.Intensity.N,0.5045884882103194,
HS2024_5_B_N1,0.4876960534196992,
FSO2013_Ratio H/M normalized Rep3___3,0.48914932655548643,
AH2018_TMTMS2_2_C,0.49464048667414523,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.4719958409685917,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.49263605932470655,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.4914374581862457,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.4930178522577035,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,0.47652702702889677,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.48705759197960835,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.4915685652158295,
JJ2018_Ratio H/L normalized pP3___1,0.49985072376177125,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4998993508918738,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.48608959419720976,
FSO2013_Ratio H/L normalized Rep2___3,0.5288469826637461,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.48478678490610505,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.4848668868594153,
SR2019_MCF10A_Biol_repl_4,0.48940231690932917,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,0.48019147855036604,
CF2017_OSE 28,,
HS2024_5_B_T2,0.4824623799220908,
HS2024_6_I_T1,0.5157707625658976,
HS2024_5_B_T3,0.48610224251282375,
JJ2018_Ratio H/M normalized pP1___1,0.5006080511608614,
KBE2022_Log2_Ex_36_U,0.49331723861744026,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,0.4952083834402196,
FR2021_Intensity.N,0.5045801009567871,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.49276569263071957,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5030903788526183,
KS2014_Intensity C2,0.4970258153926626,
FSO2013_Ratio H/L normalized Rep1___2,0.4961722705060412,
RM2024_Intensity D2-2,0.5035579928611348,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.4847443734225583,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.48421390919669255,
NJH2024_Sub9_MICT_Mid,0.48019147855036604,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5046354911471879,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,0.49886628376028075,
RKK2015_TNF-α/TNF-α+SC-514,0.4939854515951945,
CR2017_Ratio Replicate 2.5,0.4962122621404075,
HS2024_3_I_T3,0.4974846030080136,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.4993564233351969,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,0.5122899466036905,
EJN2021_3_Rest_Ins,0.4946552718308051,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,0.5093600939982458,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,0.5163245304955825,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5014745577145727,
NJH2025_Sub9_HIIT_Mid,0.47158602047034737,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5082305730786584,
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,0.4823965087661801,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.4990548399662024,
JJ2018_Ratio H/M normalized pP3,0.49826882384458254,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.49825622110961904,
RCJD2014_15min_2,0.49901320469076027,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5106831398381187,
HS2024_5_B_N2,0.485621994654619,
HS2024_5_I_N1,0.47891900765026796,
HS2024_6_I_N1,0.4934074722652775,
AR2021_KD 48h,0.49260683537120564,
FR2021_Intensity.B,0.5041661781425104,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.48459968045488466,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,0.5028073873431422,
WZ2023_Pe_005_10min,0.4952881487413814,
KBE2022_Log2_Ex_29_U,0.49131421833537176,
HS2024_7_B_T1,0.49543150889309984,
AH2018_LFQ_M_2_X,0.4949804002797321,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.480378463722857,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.49827940334621235,
JJ2018_Ratio M/L normalized pP3___1,0.5016462290154665,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5024997632145933,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4891264812941591,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.49735193930609783,
RN2012_H01,0.505188679381164,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5033920674065626,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.5157820589056521,
YA2020_Reporter_intensity_Cancer_No.3,0.49085879148979106,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.49905177309231974,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.49006393727444886,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.4999047485888559,
KS2014_Intensity C1,0.49665710890381376,
FSO2013_Ratio H/M normalized Rep3___1,0.5056650348190551,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,0.5185921482763562,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.4900107537623509,
AH2018_SILAC_M_2_X,0.4877280248386595,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5001921130263801,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.495215604389853,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.4949146068244967,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,0.525910112167872,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5127319097928267,
GF2025_P8_Adh,0.513747707639362,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.5075061803182952,
GF2025_P5_Sph,0.5039993545075463,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,0.4819008616785534,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.49418789514721095,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,0.4973477712557542,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,0.49972546668622464,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.4853536692137438,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.4922530077381052,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5023985900019411,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.49463741972834385,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,0.5012729427953554,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.4956017172638038,
AR2021_L41 1 μM,0.5009499519605628,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4948729297984495,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.4946136511136325,
KS2014_Intensity C4,0.4945051687954487,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.48882358466304127,
NJH2025_Sub9_MICT_Pre,0.48304922055411575,
RCJD2014_20min_1,0.5044694638155165,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.5122870912146438,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,0.5051956797971703,
SR2019_MCF10A_Biol_repl_3,0.49340766091135185,
HS2024_7_B_T2,0.48858183799528015,
SAS2015_PLX/DMSO_Exp3,0.49182788739183864,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.48425536124669005,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.5009805302571559,
YA2020_Reporter_intensity_Cancer_No.2,0.4890432741439863,
FSO2013_Ratio H/M normalized Rep2___3,0.4682615300997275,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.49563262078171005,
RM2024_Intensity D2-2___3,0.5018207429465125,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.525397375221472,
FSO2013_Ratio M/L normalized Rep3___1,0.5154221588797651,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,0.4965593333032044,
WZ2023_Pe_010_30min,0.5028104539753644,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.4958176324268505,
ZQ2022_N3,0.4801336516608432,
HW2015_Ratio H/L normalized Exp1,0.49923459739730386,
CK2022_12 40-1,0.4883991222352109,
NJH2024_Sub7_MICT_Pre,0.47869525609517216,
ZX2022_Control Replicate 1,0.4956100272777235,
JJ2018_Ratio H/M normalized pP1,0.500790112236872,
CK2022_16 40-1,0.4882306818425284,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.48311579757796136,
AH2018_LFQ_3_X,0.49450919042018254,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,0.49641040442935136,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5048008403073698,
SR2019_HCC1954_Biol_repl_3,0.49011281285775943,
CR2017_Ratio Replicate 2.2,0.506423655749865,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),0.5135675113101636,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,0.5047401761358332,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,0.4936931311165324,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.49624220601939484,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,0.47652702702889677,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5111679466514399,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,0.4654647230628765,
AH2018_LFQ_M_3_X,0.49619827842437303,
YA2020_Reporter_intensity_Cancer_No.4,0.4904254338292606,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,0.4934873397816234,
GF2025_P4_Sph,0.5104697594011263,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),0.46170211668284733,
JJ2018_Ratio M/L normalized___1,0.5007067732235249,
FR2021_Intensity.H,0.5080426301679607,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5003795918466823,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.4740777289234414,
HS2024_8_I_T1,0.5002761209962391,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.493676816458386,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,0.4948989695859678,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,0.4654647230628765,
EJN2021_5_Ex_Ins,0.496070381440587,
HS2024_6_I_N2,0.4963886510205872,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,0.48348370799157264,
RCJD2014_15min_3,0.49173232627777547,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.48948522858284355,
HS2024_4_I_T3,0.4832936125167383,
AH2018_SILAC_1_X,0.4915844951137383,
PG2020_Intensity 10h_B,0.4846552812782228,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,0.501896046696201,
NJH2025_Sub7_HIIT_Pre,0.4752895619809012,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5094360268769385,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.48773990752491087,
SR2019_HCC1419_Biol_repl_3,0.49674571685855223,
KBE2022_Log2_Ex_14_T,0.4937309107792803,
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.498315093477874,
SAS2015_PLX/AZD_Exp3,0.49034503858191925,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
